Skip to main content
ZheJiang Tailin Bioengineering Co.,Ltd logo

ZheJiang Tailin Bioengineering Co.,Ltd — Investor Relations & Filings

Ticker · 300813 ISIN · CNE100003S89 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,000 across all filing types
Latest filing 2019-12-30 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300813

About ZheJiang Tailin Bioengineering Co.,Ltd

https://www.tailingood.com

ZheJiang Tailin Bioengineering Co.,Ltd. specializes in the research, development, and manufacturing of high-tech equipment for life sciences and pharmaceutical engineering. The company provides integrated solutions for microbial control, sterility testing, and aseptic processing. Its core product portfolio includes sterility test canisters and pumps, microbial limit testing systems, and hydrogen peroxide vapor (VHP) decontamination units. Tailin also develops advanced isolator technology for containment and aseptic applications, alongside analytical instruments such as Total Organic Carbon (TOC) analyzers and filter integrity testers. These products are designed to meet international regulatory standards, including GMP, USP, and EP. The company serves sectors such as biopharmaceuticals, medical devices, and laboratory research, focusing on product safety and quality through specialized engineering and microbial detection technologies.

Recent filings

Filing Released Lang Actions
上海市锦天城律师事务所关于公司首次公开发行股票并在创业板上市的补充法律意见书(二)
Regulatory Filings Classification · 95% confidence The document is a detailed legal opinion letter from a law firm regarding the initial public offering (IPO) and listing of Zhejiang Tailin Biotechnology Co., Ltd. on the Growth Enterprise Market. It includes extensive legal verification and opinions on the company's qualifications, shareholder changes, compliance with laws and regulations, and other substantive matters related to the IPO process. The document references audit reports, legal opinions, and regulatory approvals, indicating it is a comprehensive legal opinion related to the IPO process rather than a financial report or announcement. It is not a financial statement, earnings release, or management discussion, nor is it a simple announcement or certification. The document is a legal opinion letter supplementing previous legal opinions, which is a specialized regulatory filing related to securities issuance and listing. Therefore, the most appropriate classification is Regulatory Filings (RNS), as it is a regulatory compliance document that does not fit into other specific financial report categories.
2019-12-30 Chinese
上海市锦天城律师事务所关于公司首次公开发行股票并在创业板上市的补充法律意见书(一)
Regulatory Filings Classification · 95% confidence The document is a detailed legal opinion letter from a law firm regarding Zhejiang Tailin Biotechnology Co., Ltd.'s initial public offering (IPO) and listing on the Growth Enterprise Market (创业板). It includes extensive legal verification, audit report references, business descriptions, related party transactions, asset details, and contract information. The document is not a financial report like an annual or interim report, nor is it a simple announcement. It is a legal opinion related to the IPO process, which is a specialized regulatory filing. Given the nature of the document as a legal opinion letter supporting the IPO and listing, it fits best under Regulatory Filings (RNS), which covers miscellaneous regulatory announcements and compliance documents that do not fit other categories. The document is lengthy (15,000 characters) and contains substantive content, not just a brief announcement or certification. Therefore, the classification is RNS with high confidence.
2019-12-30 Chinese
审阅报告
Interim / Quarterly Report Classification · 95% confidence The document is titled as an "审阅报告" which translates to "Review Report" and includes detailed financial statements such as consolidated and parent company balance sheets, profit statements, cash flow statements, and notes. It specifically mentions the review of the 2019 third quarter financial statements (2019年第三季度财务报表) including data as of September 30, 2019, and covers the period July to September and January to September 2019. The report is prepared by a registered accounting firm following Chinese CPA review standards (审阅准则第2101号). The content includes detailed financial data and analysis, not just an announcement or certification. This matches the definition of an Interim / Quarterly Report (IR), which is a comprehensive financial report for a period shorter than a full fiscal year containing actual financial statements and substantive financial data. Therefore, the document is best classified as an Interim / Quarterly Report (IR).
2019-12-30 Chinese
第二届董事会第四次会议决议等
Regulatory Filings
2019-12-30 Chinese
公司章程(草案)
Governance Information Classification · 100% confidence The document is a detailed company charter (章程) draft for Zhejiang Tailin Bioengineering Co., Ltd. It includes comprehensive sections on company governance, shareholder rights, board structure, share issuance, share transfer, shareholder meetings, and other corporate governance matters. The content is focused on the internal rules, organizational structure, and governance practices of the company rather than financial results, audit opinions, or meeting announcements. There is no indication that this is an announcement or summary of a report, nor is it a transcript or legal proceeding update. The document aligns with the definition of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2019-12-30 Chinese
发行人控股股东、实际控制人对招股说明书的确认意见
Regulatory Filings Classification · 100% confidence The document text is extremely short (61 characters) and contains no substantive content, financial data, or any indication of report type. It appears to be a placeholder or an omitted image with no meaningful information. Given the lack of content, it cannot be classified as a report or announcement. According to the rules, such minimal content defaults to Regulatory Filings (RNS) as a fallback category.
2019-12-30 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.